Targeting the Ubiquitin—Proteasome Pathway in Breast Cancer
- 1 June 2004
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 5 (2) , 148-157
- https://doi.org/10.3816/cbc.2004.n.020
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- The proteasome: a suitable antineoplastic targetNature Reviews Cancer, 2004
- Cyclin E and Survival in Patients with Breast CancerNew England Journal of Medicine, 2002
- Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agentsDrug Resistance Updates, 2000
- Cleavage motifs of the yeast 20S proteasome β subunits deduced from digests of enolase 1Proceedings of the National Academy of Sciences, 1998
- Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomasNature Medicine, 1997
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patientsNature Medicine, 1997
- Induction of Mammary Gland Hyperplasia and Carcinomas in Transgenic Mice Expressing Human Cyclin EMolecular and Cellular Biology, 1997
- Cancer Cell CyclesScience, 1996
- Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic miceNature, 1994